Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

LLY vs NVS: stock comparison and AI forecast

Eli Lilly & Co (LLY) and Novartis Ag (NVS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
NYSE · Pharmaceutical Preparations

LLY Eli Lilly & Co

Price
$1364.73 +40.0% · 6M
Market Cap
$1.28T
P/E Ratio
44.3x
Size
mega-cap
AI Forecast
Full analysis →
NYSE · Pharmaceutical Preparations

NVS Novartis Ag

Price
$162.55 +11.8% · 6M
Market Cap
$310.17B
P/E Ratio
9.8x
Size
mega-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

6M · 2026-05-07 → 2026-11-06

Six-month price performance

Closing prices rebased to 100 at the start of the window.

105120135
LLY +40.0% NVS +11.8%
LLY · NVS

Key facts

  • LLY is 4.1 times larger than NVS by market capitalization ($1.28T against $310.17B).
  • NVS trades at 9.8 times trailing earnings, LLY at 44.3 times.
  • Over the last six months LLY returned +40.0% and NVS +11.8%.
  • LLY carries 3.36 times debt per unit of equity, against 1.40 times for NVS.
  • LLY yields 0.47% in dividends; NVS pays none.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricLLYNVS
Market Cap$1.28T$310.17B
P/E Ratio44.29x9.75x
P/B Ratio130.62x–
Dividend Yield0.47%–
EPS$30.81$16.67
Book Value/Share$10.45–
Revenue/Share$91.91–
FCF/Share–$23.48

Profitability & Margins

MetricLLYNVS
ROE–72.0%
ROA–29.9%
ROIC–49.1%
Gross Margin83.6%–
EBT Margin135.0%–
Tax Rate20.7%13.5%

Financial Health

MetricLLYNVS
Current Ratio1.39x1.12x
Quick Ratio1.00x0.89x
D/E Ratio3.36x1.40x
Financial Leverage–2.41x
Working Capital$18.27B$3.18B

Cash Flow

MetricLLYNVS
Operating Cash Flow$30.64B$48.30B
Free Cash Flow–$44.80B
Capital Spending–-$3.50B
OCF Growth YoY90.8%34.1%
FCF Growth YoY–0.0%

Operational Efficiency

MetricLLYNVS
Receivables Turnover3.9x–
Inventory Turnover0.8x5.3x
Fixed Assets Turnover2.7x–
Days Sales Outstanding93 days–
Days Inventory469 days69 days
Payables Period149 days–
Cash Conversion Cycle413 days–

Income Statement

MetricLLYNVS
Total Revenue$86.46B–
Operating Income–$41.07B
Net Income–$33.21B
R&D Expense$15.38B$26.32B
SG&A Expense$12.62B$32.35B
Cost of Goods Sold$14.15B$33.02B

Dividend & Shareholder Information

MetricLLYNVS
Dividends Per Share$6.36–
Payout Ratio20.6%–
Shares Outstanding941M1908M
Net Income Growth–28.6%
EPS Growth50.7%37.2%
FAQ

LLY vs NVS: stock comparison and AI forecast

Which is bigger, LLY or NVS?

LLY is 4.1 times larger than NVS by market capitalization ($1.28T against $310.17B).

Which is cheaper on earnings, LLY or NVS?

NVS trades at 9.8 times trailing earnings, LLY at 44.3 times.

Which stock performed better over the last six months, LLY or NVS?

Over the last six months LLY returned +40.0% and NVS +11.8%.

Which one does Intratio's AI model rank higher, LLY or NVS?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.